11. THYMOMA
⢠SEEN BETWEEN 40 â 60 YRS
⢠ASSOCIATED WITH PARANEOPLASTIC
SYNDROMES LIKE MYASTHENIA , RED CELL
APLASIA, HYPOGAMMAGLOBLINEMIA, SLE
⢠2 STAGINGS â MASAOKA AND WHO
12. Stage I â Completely encapsulated .
Stage II â Capsular invasion.
IIA: Microscopic capsular invasion
IIB: Macroscopic invasion into surrounding fatty
tissue or adherent to but not through the mediastinal
pleura or pericardium
Stage III â Pericardial or lung involvement.
IIIA: Macroscopic invasion into pericardium or lung
without great vessel invasion
IIIB: Macroscopic invasion into pericardium or lung
with great vessel invasion
Stage IV â Disseminated disease.
IVA: Pleural or pericardial dissemination
IVB: Lymphatic or hematogenous metastases
13. TREATMENT :
STAGE 1 AND 2 â COMPLETE RESECTION
STAGE 3 AND 4 â COMPLETE RESECTION +
POST OP RADIATION
POST OP CHEMOTHERAPY â CISPLATIN,
DOXORUBICIN, CYCLOPHOSPHAMIDE
IN UNRESECTABLE TUMOR â PRE OP
CHEMOTHERAPY [OR] RADIOTHERAPY IS DONE .
15. NEUROGENIC TUMORS
⢠ORIGIN
SYMPATHETIC GANGLIA :â
GANGLIOMA
GANGLIO-NEUROBLASTOMA
NEUROBLASTOMA
NERVE SHEATH :â
NEUROLEMOMA(SCHWANOMA)
NEUROFIBROMA
NEUROSARCOMA
PARAGANGLION CELLS :-
PHEOCHROMOCYTOMA
NEUROBLASTOMA
⢠CHILDHOOD TUMOR
⢠COMMONLY SEEN IN ADRENAL MEDULLA
OTHER SITE â SYMPATHETIC CHAIN
⢠ARISE FROM NEUROBLASTIC CELLS
⢠C/F â MASS IN LOIN OR CHEST (PRESSURE SYMPTOM)
OTHER MANIFESTATIONS - RACOON EYE SIGN ,
OPSOMYOCLONUS SYNDROME , HYPERTENSION
, FLUSHING , DIARRHOEA (VIP)
⢠INVESTIGATION â CT OR MRI , VANILYL
MANDELIC ACID (VMA ) , HOMOVANILIC ACID
(HVA) , MIBG( META IODO BEZYL GUANIDINE)
SCAN , BONE MARROW BIOPSY
16. GRADING OF NEUROBLASTOMA
BASED ON AGE , EXTENT OF DISEASE , HISTOLOGY ,
N-MYC ONCOGENE
LOW RISK 90% - SURGICAL EXCISION
INTERMEDIATE RISK 70 % â EXCISION AND
RADIOTHERAPY
HIGH RISK 30 % â DEBULKING , RADIATION AND
CHEMOTHERAPY (CISPLATIN , DOXORUBICIN ,
CYCLOPHOSPHAMIDE ) AND SECOND LOOK
SURGERY
17. NEUROGENIC TUMORS
⢠ORIGIN
SYMPATHETIC GANGLIA :â
GANGLIOMA
GANGLIO-NEUROBLASTOMA
NEUROBLASTOMA
NERVE SHEATH :â
NEUROLEMOMA(SCHWANOMA)
NEUROFIBROMA
NEUROSARCOMA
PARAGANGLION CELLS :-
PHEOCHROMOCYTOMA
PHEOCHROMOCYTOMA
⢠TUMOR ARISES FROM CHROMAFFIN CELLS
⢠SEEN COMMONLY IN ADRENAL MEDULLA
EXTRA ADRENAL ( PARAGANGLIONS )
⢠THESE TUMOR SECRETES NORADRENALINE AND
ADRENALINE
⢠RULE OF 10âS :â 10% - MALIGNANT ,
EXTRAADRENAL , BILATREAL , FAMILIAL , MULTIPLE
, NON HYPERTENSIVE
⢠CLINICAL FEATURES â HEADACHE , PALPITATION ,
FLUSHING , WEAKNESS , HYPERTENSION ,
⢠ASSOSIATED WITH MEN 2 , VHL , NF TYPE 1 .
18. ⢠INVESTIGATION â
24 HR URINE OR BLOOD SAMPLE - METANEPHRINE &
NORMETANEPHRINE
MRI FOR LOCALISATION
MIBG SCAN
⢠TREATMENT :â
INTIALLY Îą- BLOCKER (PHENOXYLBENZAMINE) IS GIVEN
FOR 10 DAYS
THEN START β â BLOCKERS
SURGICAL EXCISION OF TUMOR IS DONE .
MALIGNANT PHEOCHROMOCYTOMA â SURGERY + I-131 MIBG
+ POST OP CHEMOTHERAPY - MITOTANE +
CYCLOPHOSPHAMIDE , VINCRISTINE , DACARBAZINE .
19. NEUROGENIC TUMORS
⢠ORIGIN
SYMPATHETIC GANGLIA :â
GANGLIOMA
GANGLIO-NEUROBLASTOMA
NEUROBLASTOMA
NERVE SHEATH :â
NEUROLEMOMA(SCHWANOMA)
NEUROFIBROMA
NEUROSARCOMA
PARAGANGLION CELLS :-
PHEOCHROMOCYTOMA
NEUROFIBROMA
â˘ARISE FROM SCHWANN CELLS AND CONNECTIVE TISSUES
â˘TYPES â CUTANEOUS â SMALL , HARD , MULTIPLE NODULES
PLEXIFORM â LARGE , HARD MASS
NON TENDER , PARAESTHESIA ,MOVE PERPENDICULAR TO THE NERVE
â˘COMMONLY ASSOCIATED WITH NEUROFIBROMATOSIS
TYPE 1 â CHROMOSOME 17 MUTATION , NF-1 GENE .
OTHER FEATURES â AXILLARY FRECKLES , LISCH NODULES,
CAFĂ AU LAIT SPOT .
INVESTIGATION â CT/MRI , SLIT LAMP , MOLECULAR
TESTING .
TREATMENT â SURGICAL EXCISION
20. NEUROGENIC TUMORS
⢠ORIGIN
SYMPATHETIC GANGLIA :â
GANGLIOMA
GANGLIO-NEUROBLASTOMA
NEUROBLASTOMA
NERVE SHEATH :â
NEUROLEMOMA(SCHWANOMA)
NEUROFIBROMA
NEUROSARCOMA
PARAGANGLION CELLS :-
PHEOCHROMOCYTOMA
SCHWANNOMA
â˘ARISE FROM SCHWANN CELLS , BENIGN TUMORS
â˘CAN OCCUR AT ANY SITE
â˘ASSOCIATED WITH NEUROFIBROMATOSIS TYPE - 2
CAUSING ACOUSTIC NEUROMA .
â˘C/F â HEARING LOSS , PARAESTHESIA , SOMETIMES
TENDER .
⢠INVESTIGATION â CT/MRI , AUDIOMETRY .
⢠TREATMENT â SURGICAL EXCISION